SeaLife Pharma is a biotechnology company specializing in the discovery and development of marine-derived pharmaceuticals. The company focuses on creating innovative treatments for unmet medical needs by harnessing the unique properties of marine organisms. Operating in the biopharmaceutical market, SeaLife Pharma serves healthcare providers, research institutions, and pharmaceutical companies. The business model revolves around research and development, followed by licensing and partnerships with larger pharmaceutical firms for commercialization. Revenue is generated through licensing agreements, milestone payments, and royalties on sales of developed drugs. The company leverages its expertise in marine biology and pharmaceutical sciences to maintain a competitive edge in the market.

Keywords: marine-derived, pharmaceuticals, biotechnology, healthcare, research, development, licensing, partnerships, innovation, sustainability.